SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
lyq007
Lv5
1
930 积分
2023-09-25 加入
最近求助
最近应助
互助留言
Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations
27天前
已完结
Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes
27天前
已完结
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion
28天前
已完结
Sunvozertinib: the next candidate of TKI for NSCLC
1个月前
已完结
sunvozertinib:the next candidate of TKI for NSCLC
1个月前
已关闭
Clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in completely resected lung adenocarcinoma
3个月前
已完结
EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study
3个月前
已完结
Response assessment criteria for brain metastases: proposal from the RANO group
3个月前
已完结
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
4个月前
已完结
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
4个月前
已完结
Phase 1/2a study of AZD5305, a novel poly(adenosine diphosphate ribose) polymerase (PARP) 1-selective inhibitor in combination with new hormonal agents (NHAs) in patients (pts) with metastatic prostate cancer (mPC)
3个月前
已采纳
Phase 1/2a study of AZD5305, a novel poly(adenosine diphosphate ribose) polymerase (PARP) 1-selective inhibitor in combination with new hormonal agents (NHAs) in patients (pts) with metastatic prostate cancer (mPC)
3个月前
已采纳
没回复【积分已退回】
1个月前
速度真快,帮大忙了,么么哒
3个月前
感谢,点赞
3个月前
点赞,速度真快
3个月前
速度真快
5个月前
帮大忙了,速度真快
5个月前
点赞,速度真快,帮大忙了
5个月前
点赞,速度真快
6个月前
感谢,点赞,速度真快,帮大忙了,么么哒
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论